Premium Nahrungsergänzungsmittel | artgerecht

Fibrinogen – Function, Normal Levels & Importance

Fibrinogen is a vital blood clotting protein produced in the liver that plays a central role in wound healing and the formation of blood clots.

Regular tips about health Regular tips about health

Things worth knowing about "Fibrinogen"

Fibrinogen is a vital blood clotting protein produced in the liver that plays a central role in wound healing and the formation of blood clots.

What is Fibrinogen?

Fibrinogen is a soluble glycoprotein found in blood plasma, produced by the liver, and known as clotting factor I. It is an essential component of the blood coagulation system, enabling the formation of a stable blood clot following injury. In healthy adults, the normal fibrinogen concentration in the blood ranges between 2 and 4 g/L.

Mechanism of Action

When a blood vessel wall is injured, the body activates a cascade of clotting factors. At the end of this coagulation cascade, the enzyme thrombin converts the soluble fibrinogen into insoluble fibrin monomers. These monomers spontaneously assemble into a fibrin network that traps red blood cells and platelets, forming a firm blood clot (thrombus). Clotting factor XIII further cross-links the fibrin strands to mechanically stabilize the clot.

Biological Functions

Hemostasis: Fibrinogen is essential for primary and secondary hemostasis following vascular injury.
Wound healing: The fibrin network serves as a scaffold for migrating cells that repair damaged tissue.
Inflammatory response: Fibrinogen is an acute-phase protein and its levels rise in the blood during inflammation, infection, or tissue damage.
Cell communication: Fibrinogen and its degradation products interact with various cell receptors, influencing inflammatory and immune processes.

Clinical Relevance – Fibrinogen Testing

Measuring fibrinogen levels in the blood is an important diagnostic parameter. Deviations from the normal range can indicate various medical conditions.

Elevated Fibrinogen (Hyperfibrinogenemia)

Elevated fibrinogen levels (above 4 g/L) may indicate the following conditions:

Acute or chronic inflammation
Infection and sepsis
Heart attack or stroke (as a risk factor)
Malignancies (cancer)
Pregnancy
Cigarette smoking

Chronically elevated fibrinogen is considered an independent risk factor for cardiovascular disease, as it promotes blood coagulation and increases the risk of thrombosis.

Low Fibrinogen (Hypofibrinogenemia or Afibrinogenemia)

Abnormally low fibrinogen levels (below 2 g/L) can occur in:

Congenital fibrinogen deficiency disorders (e.g., congenital afibrinogenemia)
Severe liver disease (since fibrinogen is produced in the liver)
Disseminated intravascular coagulation (DIC) – a life-threatening condition involving excessive consumption of clotting factors
Massive blood loss
Certain medications (e.g., fibrinolytic agents)

Diagnosis and Reference Values

Fibrinogen levels are determined through a standard blood draw. Measurement is performed in a medical laboratory using the Clauss method, which measures the time it takes for plasma to clot after the addition of thrombin. Reference values for healthy adults are generally between 2.0 and 4.0 g/L. During pregnancy, values up to 6.0 g/L are considered physiologically normal.

Treatment of Fibrinogen Deficiency

In cases of severe fibrinogen deficiency leading to life-threatening bleeding, the following treatment options are available:

Fibrinogen concentrate: Administered intravenously to rapidly restore fibrinogen levels.
Fresh frozen plasma (FFP): Contains all clotting factors including fibrinogen.
Cryoprecipitate: A blood product rich in fibrinogen, factor VIII, and von Willebrand factor.

References

Mosesson, M. W. (2005). Fibrinogen and fibrin structure and functions. Journal of Thrombosis and Haemostasis, 3(8), 1894–1904.
Lowe, G. D. O. (2004). Fibrinogen and cardiovascular disease: historical introduction. European Heart Journal Supplements, 6(Suppl A), A1–A5.
World Health Organization (WHO). Use of anticoagulants and fibrinogen-modifying agents in clinical medicine. WHO Technical Report Series. Geneva: WHO Press.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.